Related references
Note: Only part of the references are listed.Astragalus species: Insights on its chemical composition toward pharmacological applications
Bahare Salehi et al.
PHYTOTHERAPY RESEARCH (2021)
Astragaloside IV Improves High-Fat Diet-Induced Hepatic Steatosis in Nonalcoholic Fatty Liver Disease Rats by Regulating Inflammatory Factors Level via TLR4/NF-κB Signaling Pathway
Ying-Li Liu et al.
FRONTIERS IN PHARMACOLOGY (2021)
Associations Between Using Chinese Herbal Medicine and Long-Term Outcome Among Pre-dialysis Diabetic Nephropathy Patients: A Retrospective Population-Based Cohort Study
Jenny Chun-Ling Guo et al.
FRONTIERS IN PHARMACOLOGY (2021)
Finerenone and Chronic Kidney Disease Outcomes in Type 2 Diabetes
Donald Baumstein
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Sarcopenia, but not frailty, predicts early mortality and adverse events after emergent surgery for metastatic disease of the spine
Etienne Bourassa-Moreau et al.
SPINE JOURNAL (2020)
Special Issue Diabetic Nephropathy: Diagnosis, Prevention and Treatment
Marta Ruiz-Ortega et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Alleviation by Mahuang Fuzi and Shenzhuo Decoction in High Glucose-Induced Podocyte Injury by Inhibiting the Activation of Wnt/β-Catenin Signaling Pathway, Resulting in Activation of Podocyte Autophagy
Haoran Dai et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2020)
Dapagliflozin in Patients with Chronic Kidney Disease
Hiddo J. L. Heerspink et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
SGLT2 Inhibitors: Nephroprotective Efficacy and Side Effects
Carlo Garofalo et al.
MEDICINA-LITHUANIA (2019)
Diabetes Advocacy: Standards of Medical Care in Diabetes-2019
William T. Cefalu et al.
DIABETES CARE (2019)
Lifestyle Management: Standards of Medical Care in Diabetes-2019
William T. Cefalu et al.
DIABETES CARE (2019)
Canagliflozin and Renal Outcomes in Diabetic Nephropathy
Bruce R. Leslie et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Mangiferin prevents diabetic nephropathy progression and protects podocyte function via autophagy in diabetic rat glomeruli
Xiaodan Wang et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2018)
CKD in diabetes: diabetic kidney disease versus nondiabetic kidney disease
Hans-Joachim Anders et al.
NATURE REVIEWS NEPHROLOGY (2018)
Supplementation of Abelmoschus manihot Ameliorates Diabetic Nephropathy and Hepatic Steatosis by Activating Autophagy in Mice
Hwajin Kim et al.
NUTRIENTS (2018)
Berberine attenuates hepatic steatosis and enhances energy expenditure in mice by inducing autophagy and fibroblast growth factor 21
Yixuan Sun et al.
BRITISH JOURNAL OF PHARMACOLOGY (2018)
Effect of Saxagliptin on Renal Outcomes in the SAVOR-TIMI 53 Trial
Ofri Mosenzon et al.
DIABETES CARE (2017)
Association between changes in quality of life and mortality in hemodialysis patients: results from the DOPPS
Jeffrey Perl et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2017)
Berberine enhances the AMPK activation and autophagy and mitigates high glucose-induced apoptosis of mouse podocytes
Yingli Jin et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2017)
Chinese medicine for diabetic kidney disease in China
Yumin Wen et al.
NEPHROLOGY (2017)
Liraglutide and Renal Outcomes in Type 2 Diabetes
Johannes F. E. Mann et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Normoalbuminuric diabetic kidney disease
Chao Chen et al.
FRONTIERS OF MEDICINE (2017)
Establishing an evaluation mode with multiple primary outcomes based on combination of diseases and symptoms in TCM clinical trials
Jing Hu et al.
ANNALS OF TRANSLATIONAL MEDICINE (2017)
Diabetic Kidney Disease Challenges, Progress, and Possibilities
Radica Z. Alicic et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)
Linagliptin and its effects on hyperglycaemia and albuminuria in patients with type 2 diabetes and renal dysfunction: the randomized MARLINA-T2D trial
Per-Henrik Groop et al.
DIABETES OBESITY & METABOLISM (2017)
Azuki bean (Vigna angularis) extract reduces oxidative stress and stimulates autophagy in the kidneys of streptozotocin-induced early diabetic rats
Shin Sato et al.
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY (2016)
Effect of Sitagliptin on Kidney Function and Respective Cardiovascular Outcomes in Type 2 Diabetes: Outcomes From TECOS
Jan H. Cornel et al.
DIABETES CARE (2016)
Clinical Manifestations of Kidney Disease Among US Adults With Diabetes, 1988-2014
Maryam Afkarian et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
Steven P. Marso et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Combination Therapy with Chinese Medicine and ACEI/ARB for the Management of Diabetic Nephropathy: The Promise in Research Fragments
Xiang Tu et al.
CURRENT VASCULAR PHARMACOLOGY (2015)
Lowering blood pressure in diabetes
Seema Kang
LANCET DIABETES & ENDOCRINOLOGY (2015)
Gene Ontology Consortium: going forward
J. A. Blake et al.
NUCLEIC ACIDS RESEARCH (2015)
Blood Pressure Lowering in Type 2 Diabetes A Systematic Review and Meta-analysis
Connor A. Emdin et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Olmesartan for the Delay or Prevention of Microalbuminuria in Type 2 Diabetes
Hermann Haller et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Relation Between Kidney Function, Proteinuria, and Adverse Outcomes
Brenda R. Hemmelgarn et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Western healers in traditional Chinese medicine
Xue-Juan Li et al.
EMBO REPORTS (2008)
Share Paper
